Increased Risk for Abdominal Obesity Found in People Living With HIV

This article originally appeared here.
Share this content:
Increased risk for cardiovascular disease contributes to the lower life expectancy seen in individuals living with HIV.
Increased risk for cardiovascular disease contributes to the lower life expectancy seen in individuals living with HIV.

People living with HIV are at increased risk for abdominal obesity, hypertriglyceridemia, and elevated low-density lipoprotein (LDL) cholesterol but not hypertension, according to a recent study published in Clinical Infectious Diseases.

The study included 1099 people living with HIV from the Copenhagen Comorbidity in HIV Infection (COCOMO) study and 12,161 uninfected sex and age-matched controls from the Copenhagen General Population Study. Each participant was assessed using an identically structured questionnaire to determine demographics, smoking, physical activity, medication, and educational level. HIV infection data were obtained by a review of the COCOMO participants' medical charts.

All participants were examined by trained clinical staff using identical protocols to determine waist and hip measurements, blood pressure, body mass index (BMI), and blood levels of triglycerides, LDL-C, total cholesterol, glucose, and HbA1c. People living with HIV had lower BMI than the control participants and yet had a higher incidence of abdominal obesity (63.5% vs 59.8%, P =.018). People living with HIV also showed a higher prevalence of hypertriglyceridemia than control participants but a lower prevalence of hypertension. Exploratory analysis showed that an increased risk for metabolic syndrome was associated with HIV infection.

Abdominal obesity is associated with increased risk for cardiovascular disease and cardiovascular disease risk factors. Cardiovascular disease is the principal contributor to non-AIDS mortality and morbidity in people living with HIV. Earlier generations of antiretroviral treatments (ART) for HIV resulted in a high incidence of fat redistribution syndrome, which declined after the introduction of combination ART (cART) with only minor metabolic  side effects. However, this study revealed that HIV was associated with an increased risk for abdominal obesity even after stratifying participants according to cART initiation date, suggesting that either HIV itself increases this risk, or modern cART still contributes to fat redistribution syndrome.

At a given BMI, the association between abdominal obesity and HIV was exacerbated by age. The study investigators hypothesize that both age and HIV-associated fat redistribution syndromes are amplified by parallel yet interconnected pathways that lead to a synergistic interaction between HIV infection and aging.

zThe investigators conclude that this study suggests fat redistribution syndrome and abdominal obesity remain prominent features of people living with HIV and may partly explain “the continued excess risk for premature carxenewed attention by the medical community [toward] the abdominal obesity phenotype, and innovative interventions targeting this condition are therefore needed in order to reduce the risk [for] cardiovascular disease in people living with HIV.”

Reference

Gelpi M, Afzal S, Lundgren J, et al. Higher risk of abdominal obesity, elevated LDL cholesterol and hypertriglyceridemia, but not of hypertension, in people living with HIV: results from the Copenhagen Comorbidity in HIV infection (COCOMO) study [published online February 17, 2018]. Clin Infect Dis. doi: 10.1093/cid/ciy146

You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters

CME Focus